A life sciences commercialization company, recently listed in may'24. Company has
1. Been profitable and poised for the growth trajectory
2. Good sales expansion
3. Business space is kind of a moat
4. Excellent support zone as indicated
5. Excellent ROCE and operating margins
1. Been profitable and poised for the growth trajectory
2. Good sales expansion
3. Business space is kind of a moat
4. Excellent support zone as indicated
5. Excellent ROCE and operating margins
交易進行
A proxy for life sciences/pharma cos investment!
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。